Authors
Latest:
What Patients On a Vegan Diet Need to Know About MedicationsAnimal products are prevalent in pharmaceuticals manufacturing, including in some unexpected places.
Latest:
Daily Dose and Costs of Therapy With Topical Testosterone AgentsWe assessed time to maintenance dose attainment in commercially insured men initiating topical testosterone agents and compared daily maintenance doses and costs of this therapy.
Latest:
Dementia Is Common and Somewhat TreatableMany treatments are off-label, so pharmacists can educate clinicians and help patients with access.
Latest:
How Will Pharmacists Practice in 2015: A 2017 ResponsePharmacists must continue to evolve to the needs of their patients and always remain a key player in health care decisions.
Latest:
Fraud Cases Underscore New Challenges for Compounding PharmaciesCompounded drugs accounted for more than half of cost increases under Medicare Part D in the last year.
Latest:
Comparison of Pharmacists and Primary Care Providers as ImmunizersPharmacist-administered vaccination services were found to be more efficient, productive, and cost-effective than primary care visits or mass vaccination clinics.
Latest:
Look and Look Again -- Getting to Know the Community Pharmacy FoundationAlthough its organizational infrastructure is virtual, the Community Pharmacy Foundation (CPF) is ‘anything but’ and is quite quantifiable and impactful in its vision, mission, and deliverables.
Latest:
Continuity of Care: Diabetic Neuropathy: Bridging the Sensation GapPharmacists in all health care settings play an important role in the prevention and treatment of diabetic neuropathy.
Latest:
USP Chapter : Nonsterile Compounding Pharmacy Air Flow ConsiderationsUSP Chapter presents many challenges for pharmacies and other health care settings, especially compounding pharmacies.
Latest:
A New Monoclonal Antibody for R/R MM: Isatuximab-irfcIsatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.
Latest:
Drug Diversion: New Approaches to an Old ProblemDrug diversion in hospitals continues to be problematic. Heightened DEA activity and opioid addiction reaching epidemic proportions require hospitals to be more vigilant than ever.
Latest:
The Changing Clinical Assessment: An Overview and Next-Level ChallengesThe clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.
Latest:
Walmart Essay Winner: A Community Pharmacist's Impact Can Go a Long Way"The total time that I spent with this man was less than 20 minutes, but the impact that I had on his life when he thought he was all alone will last a lifetime."
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Unanticipated Learning Opportunities for Pharmacy Students During COVID-19The coronavirus disease 2019 pandemic has presented pharmacy students with an opportunity to develop new skills that former students never had the opportunity to develop.
Latest:
Biopharmaceuticals: A Way Forward for Biogenerics?Although the demand for generic competition in the biopharmaceutical market could potentially be great, regulators have been slow to clear a pathway for the approval of generic biopharmaceuticals.
Latest:
Specialty Pharmacies May Improve Care for Hemophilia, vWD PatientsTo improve the care of patients with hemophilia and von Willebrand's Disease (vWD), coagulation factor products should be billed through the pharmacy benefit and provided by specialty pharmacies, the authors of a new study suggest.
Latest:
Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic TherapiesAmong psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.
Latest:
Understanding Predictors of Opioid Abuse: Predictive Model Development and ValidationThis study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.
